Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects

NCT05369767 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of Arterial and Venous Thrombosis

Interventions

DRUG: SAD, SHR-2004
DRUG: SAD, SHR-2004 placebo

Sponsor

Beijing Suncadia Pharmaceuticals Co., Ltd